This a repost of mine from yahoo site answering questions and comments.
They never failed
They shut down photogen to start pvct when they figured out they had a better product
They did get paid a few years a bunch.... They also are getting a product to market for around $130mm instead of $1.5 billion and in less time than normal.... We benefited from that because there are no partners to share in the end game... Probably would not be an end game otherwise....they would have taken over and you might have gotten a few bucks increase instead of the big payoff that's coming
They did not go for pIII right away when they realized they could invent a new synthesis for rb that can be approved internationally for oncology....99% purity
Patent awarded this year ....you have to go into pIII with the drug that gets approved...so they waited for the patent
PIII? No mention in 8k..... What was mentioned was btd and aa
Deliberate omission? Judge for yourself.
Large production runs done for Nda and ready to ship...hmmmmm.
Second Pfizer guy on advisory board with Chinese pharma experience
They have been working on a Chinese regional deal waiting on FDA clarity....hmmmmm
First Pfizer board member is an acquisition specialist.....hmmmmm
They changed their name and state of incorporation......around same time as FDA meeting.....hmmmmm
Pfizer losing patents on Lipitor and Viagra .....hmmmmm
You guys not getting this......???? hmmmmmm...